Li Lab

Expert opinion on emerging drugs · 2026

Early investigational agents for the treatment of rosacea: drugs in phase II and III clinical development

Tian, K. and Li, J. and Wang, B.

doi:10.1080/14728214.2026.2655714


Abstract

Rosacea is a chronic inflammatory facial skin disease with an incompletely understood pathogenesis and limited efficacy of current treatments. A number of clinical trials are underway for the development of new drugs to improve patient care.

← Back to publications